I was delighted to meet Hologic, a global medical technology company and specialist in high-volume population screening, this morning.
Hologic is an expert in women’s health, providing the technology that underpins breast cancer screening in the UK, and they contacted me because I recently spoke in a debate on breast cancer screening in the House of Commons.
It was great to hear how their innovative technology could address some of the challenges in breast screening in the UK. It was also good to hear that as well as providing the technology to support screening services, Hologic has recently run campaigns to encourage people to attend screening invitations for both breast and cervical health.
Initiatives like this are more important than ever as we continue to tackle COVID–19.
